CAS: 13027-88-8; 2-Hydroxy-2-Methylpropanamide

该化合物是一种有机化合物,其特征为氨化功能组和附属于分碳链的氢氧基化合物,其结构有分子式,包括一个碳原子中央原子,与一个氢氧组,一个甲基组和一个氨化物组捆绑在一起.该化合物一般是一种在室温下的白色晶状固体,由于存在可进行氢结合的氢氧和氨化物功能,在极地溶剂中可溶解.其特性使其与各种化学应用有关,包括作为有机合成和制药工业的一个建筑块.该氢氧基组的存在还表明,在凝聚反应中或作为进一步功能化的场所,具有再活性的潜力.安全数据表明,与许多氨化物一样,它应该谨慎处理,因为它在与皮肤或眼睛接触时可能会引起刺激.

结构式图片

相似化合物

2854-16-2 598-81-2 2043-43-8

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号75-86-5 丙酮氰醇 | CAS号110434-78-1 3-Benzyloxy-4,4... | CAS号56756-91-3 Propanenitrile,... | CAS号74-90-8 氢氰酸 | CAS号67-64-1 丙酮 | CAS号855636-80-5 α-(α-hydroxy-is... | CAS号7664-38-2 磷酸 | CAS号19355-69-2 N-氰基-N'-甲基乙脒 | CAS号594-61-6 2-羟基异丁酸 | CAS号49562-37-0 2-methyl-2-(sul... | CAS号79-41-4 甲基丙烯酸 | CAS号6713-72-0 3,3,6,6-tetrame... | CAS号2539-76-6 ammonium 2-hydr... | CAS号67-63-0 异丙醇 | CAS号67-64-1 丙酮 | CAS号594-61-6 2-羟基异丁酸 | CAS号2110-78-3 2-羟基异丁酸甲酯 | CAS号82473-56-1 2-methoxy-2-met... | CAS号6862-08-4 2,2,5,5-Tetrame... | CAS号49562-37-0 2-methyl-2-(sul...

合成工艺路线路线简述

  • 合成目标产物 2-Methyl-2-Hydroxypropionamide 主要起始原料 Acetone Cyanohydrin
  • (文献来源)合成步骤主要原料 Acetone Cyanohydrin
丙酮氰醇置于己酰胺,溶剂黄146,Palladium (II) Nitrate体系中,化学反应 0.67H,以94%的收率获得2-羟基异丁酰胺
参考文献:氰醇催化转移水合为 α-羟基酰胺
标题:氰醇催化转移水合为 α-羟基酰胺
摘要:我们报告了通过使用羧酰胺作为水供体,钯 (II) 催化的氰醇转移水合为 α-羟基酰胺.该方法能够在温和条件下(50°C,10 分钟)选择性地水合各种醛和酮衍生的氰醇,分别提供 α-单-和 α,α-二取代-α-羟基酰胺.非诺贝特(一种带有二苯甲酮部分的药物)直接转化为功能化的 α,α-二芳基-α-羟基酰胺是通过氢氰化-转移水合序列实现的.初步动力学研究和位点特异性 18O 标记的 α-羟基酰胺的合成证明了羰基氧从羧酰胺试剂转移到 α-羟基酰胺产物中.
Doi:10.1021/jacs.8B12877

海关参考信息

专利信息


专利号:US-6995284-B2
优先权日:2000-08-24
标题 :Synthesis of selective androgen receptor modulators
发明人:DALTON JAMES T; MILLER DUANE D; HE YALI; YIN DONGHUA
权利人:UNIV TENNESSEE RES FOUNDATION
摘要:The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds which are selective androgen receptor modulators (SARM) which are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and/or prevention of chronic muscular wasting; e) decreasing the incidence of, halting or causing a regression of prostate cancer; f) oral androgen relacement and/or other clinical therpauetic and/or diagnostic areas. The process of the present invention is suitable for large-scale preparation, since all of the steps give rise to highly pure compounds, thus avoiding complicated purification procedures which ultimately lower the yield. Thus the present invention provides methods for the synthesis of non-steroidal agonist compounds, that can be used for industrial large-scale synthesis, and that provide highly pure products in high yield.

专利号:US-4713383-A
优先权日:1984-10-01
标 题:Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
发明人:FRANCIS JOHN E; GELOTTE KARL O
权利人:CIBA GEIGY CORP
摘要:[1,2,4]triazolo[1,5-c]quinazoline compounds of the formula wherein R1 is optionally substituted phenyl, pyridyl, furyl thienyl, dihydro or tetrahydro furanyl or thienyl, pyranyl, or 0-ribofuranosyl; R2 is hydrogen or lower alkyl; X is oxygen or NR3, R3 is as defined in the claims, and ring A is unsubstituted or substituted as set forth in the claims. The compounds wherein X is N-R3 are especially useful as adenosine antagonists and for the treatment of asthma. The compounds wherein X is oxygen are useful as benzodiazepine antagonists and as intermediates in the synthesis of the compounds wherein X is N-R3.

专利号:US-10479754-B2
优先权日:2015-09-16
标题 :Synthesis of methacrylic acid from methacrolein-based alkyl methacrylate
发明人:KRILL STEFFEN; GROEMPING MATTHIAS; LYGIN ALEXANDER
权利人:ROEHM GMBH
摘要:The present invention relates to a process for preparing alkyl methacrylates, especially MMA, and methacrylic acid, based on methacrolein, which has been oxidatively esterified in a second process stage. Methacrolein is obtainable in principle from C2 and C4 units. The present process has the advantage that the alkyl methacrylate and methacrylic acid can be obtained in a simple manner, in high yields and high purities, either as a mixture or as isolated product streams. In particular, the process of the invention has the great advantage that especially the ratio of the desired methacrylic acid and alkyl methacrylate, especially MMA, products can be adjusted freely within a wide range and varied by chemical engineering measures and operating parameters.

专利号:CN-104774891-B
优先权日:2015-01-15
标 题:A kind of technique of enzymatic efficient synthesis of benzyloxycarbonyl aspartame

专利号:JP-6824253-B2
优先权日:2015-09-16
标 题:Synthesis of methacrylic acid from methacrolein-based alkyl methacrylates

专利号:US-2018251418-A1
优先权日:2015-09-16
标题:Synthesis of methacrylic acid from methacrolein-based alkyl methacrylate
北京精益精化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.fnfchem.com
电话: 010-64446910👤
📞北京精益精化工有限公司 ⚠️参考联系方式

销售电话:010-64446910
邮箱:heyi@fnfchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知